The Government has stated that “there are no current plans” for electronic prescribing to be enabled for CBPMs from private clinics. In a response to a written question in Parliament, Health Minister Karin Smyth MP stated: “Cannabis-based products for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001. Electronic prescribing […]
Read More
The Care Quality Commission (CQC) has published a report entitled ‘The safer management of controlled drugs: Annual update 2024’. This contains a section on CBPMs. CQC note that prescriptions of unlicensed CBPMs in independent services has increased by 130% between 31 March 2023 and 31 March 2024: 1 April 2022 to 31 March 2023: 150,527 […]
Read More
The Government has recently written to the ACMD about part 2 of their ‘barriers to research’ work, with some notable developments: General: “A new cross-government officials working group will focus on any new issues involving research with controlled drugs while also monitoring the changes following your recommendations.” Recommendation 1: Research using Schedule 1 Controlled Drugs […]
Read More
The CIC has produced an Impact Report to assess the organisation’s progress over the past two years. The report largely covers the period under former Co-Chairs Dr Callie Seaman and Jamie Bartley. Read now
Read More
The Food Standards Agency (FSA) has announced some updates in their approach to the consumer CBD industry. The key developments are as follows: The FSA continue to maintain that 10mg per day is the Acceptable Daily Intake (ADI), with some exceptions. The evidence behind this position remains unpublished. The FSA have established a ‘safe upper […]
Read More
In this month’s episode, Luke speaks to Nicole Farah, Founder and MD of Americana Communications. Nicole explores the role of effective PR in shaping the narrative surrounding cannabis and influencing legislation. Throughout she unpacks the differences that define discourse and policy on both sides of the Atlantic. The podcast can be listened to now via […]
Read More
CIC CEO Mike Morgan-Giles was a guest on the Institute of Economic Affairs (IEA) podcast this week, discussing cannabis policy and much more with host Reem Ibrahim. Mike discussed the CIC’s position on cannabis matters, as well as some wider thoughts on policy in general. Watch/listen now:
Read More
Following publication of the letter from Home Office Minister Rt Hon Dame Diana Johnson MP to the ACMD this week, CIC CEO Mike Morgan-Giles commented: “The Cannabis Industry Council welcomes the Government asking the ACMD to review the state of play in the medical cannabis industry. “However, medical cannabis prescriptions in the UK lag far […]
Read More
Industry leaders Frances Crewdson and Tom Gray have been elected as the new Co-Chairs of the Cannabis Industry Council (CIC), taking on the baton from Dr. Callie Seaman and Jamie Bartley. Frances has been Chair of the CIC Standards Working Group since 2024, as well as being a Director of CannDo Consulting. Tom has been […]
Read More
Commenting on the newly published London Drugs Commission report entitled ‘The Cannabis Conundrum’, CIC CEO Mike Morgan-Giles said: “The Cannabis Industry Council welcomes this report from the London Drugs Commission. “It is beyond doubt that the current system is disproportionately impacting ethnic minority communities and reform is badly needed. “The CIC contributed to the commission’s […]
Read More